OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

BIIB143, also known as cemdomespib, was the most advanced asset to get the chop. Biogen acquired the Hsp90 modulator in 2023 through its buyout of Reata, a deal that centered on the FDA-approved ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

GRAND FORKS — A Grand Forks man is celebrating the success of a relatively new procedure for amputees, which has changed his ...

It’s a position no one wants to be in. You have sharp, debilitating pain. This is not your standard muscle tightness. This ...

LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company specializing in the development of treatments for ocular conditions and currently valued at $37 million, has ...

Understanding the risks, symptoms, and prevention methods for diabetic foot conditions is crucial for those with diabetes.

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

Unlock the mysteries of pain management by harnessing the power of fear, stress, and emotion. Discover how the brain's response to pain can be altered for more effective pain relief.

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Dr. Mary-Frances O'Connor has been studying grief for a long time. Part of her interest in the subject is personal.

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out for its potency, but above all, in comparison with opioids, for its safety," ...